K2M Receives FDA Clearance for Anterior Lumbar Stabilization System

K2M, a spinal device company focused on treatment of complex spinal pathologies, received FDA 510k clearances for its CHESAPEAKE anterior-lumbar stabilization system, according to a company news release.

Advertisement

CHESAPEAKE is an interbody device designed to stabilize the spine through an anterior approach. The system includes the tifix locking technology for screw fixation, in which each screw head forms an autogenic lock to the implant upon insertion.

CHESAPEAKE is manufactured from PEEK polymer and utilizes the anterior insertion ramp and controlled threaded insertion while applying a zero-impact load on the interbody.

Read the K2M release on CHESAPEAKE.

Read other coverage on K2M:

– Welsh Carson Acquires Spinal Device Company K2M

– K2M Introduces Two Minimally Invasive Spine Surgery Products

– K2M Launches Natural Bridge Low Profile Transverse Connectors

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.